About Radiostics

History

Radiostics was launched as a start-up company in 2013 by Andrew D. Smith, M.D., Ph.D. We offer subspecialized radiology consulting and image interpretation for clinical research organizations (CROs) and medical image annotation services to industry partners.

 

Since 2013, we have grown and increased our experience and relationships. We developed standardized operating procedures and leverage artificial intelligence technology.

Image by National Cancer Institute
Image by National Cancer Institute

press to zoom
Andrew Smith edited_edited_edited
Andrew Smith edited_edited_edited

press to zoom
Brian allen edited_edited
Brian allen edited_edited

press to zoom
Image by National Cancer Institute
Image by National Cancer Institute

press to zoom
1/4
Expertise

We have learned to focus on core areas, including oncologic imaging, musculoskeletal imaging, cardiovascular imaging, molecular imaging, and neuroimaging. We offer industry-leading medical image annotation services. Subspecialization allows us to offer the highest level of expertise to our clients.

 

Our experts are academic radiologists and other imaging specialists who have significant knowledge and expertis.

Best Assets

Our best asset is the depth of knowledge and experience of our radiologists and imaging specialists. Our innovative virtual core lab keeps overhead low and provides our experts with a deeper and broader level of experience. We govern our quality assurance and quality control (QA and QC) through rigorous standard-operating procedures and manuals.

 

Along the way, we have gained access to developed innovative technologies including AI Mass, Liver Surface Nodularity Metrics, and other developing products from AI Metrics. AI Mass reduces errors and improves accuracy, standardization, efficiency, and reporting by displaying longitudinal data in the form of a graph, table, and key images. LSN Metrics is a quantitative CT and MRI biomarker tool that is used to stage liver fibrosis, substage cirrhosis, and predict clinically-significant hypertension and liver decompensation."

Company Founder

Andrew D. Smith, M.D., Ph.D., is a practicing radiologist, physician, entrepreneur, and inventor. He completed diagnostic radiology residency and an abdominal / oncologic imaging fellowship at the Cleveland Clinic.

In 2017, Dr. Smith joined University of Alabama at Birmingham (UAB) Radiology and holds the following positions:

Prior to joining UAB, he held the following positions at the University of Mississippi Medical Center:

  • Associate Professor of Radiology

  • Vice Chair of Radiology Research

  • Director of the Medical Student Research Program

  • Director of the Clinical Investigator Pathway

  • Asso. Director of the MD PhD program

Dr. Smith has served as a reader for multiple musculoskeletal, cardiovascular, and oncologic clinical trials. He was the lead medical reviewer for the Cleveland Clinic Peripheral Vascular Core Lab.

 

He has received multiple national awards and recognition for his clinical research and has extensive clinical trial experience.


Dr. Smith serves on the following national committees:

Company COO

Brian C. Allen, M.D., is an associate professor of radiology at Duke University. He completed his medical doctorate at the Medical College of Wisconsin and is a certified member of the American Board of Radiology.

His clinical and research interests are:

  • Oncologic imaging

  • Metastatic tumor response

  • Renal cell carcinoma

  • Urothelial carcinoma

  • Gynecologic carcinomas

  • Sarcomas

Dr. Allen is co-author of a review of imaging in clinical staging of renal cell carcinoma in the  the American Journal of Roentology.

Brian allen edited.png